Paper8329698
High proliferative potential colony-forming cell heterogeneity identified using counterflow centrifugal elutriation.
Yoder MC and 2 others. Blood, 1993. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. High proliferative potential colony-forming cell heterogeneity identified using counterflow centrifugal elutriation. Papers, record 8329698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8329698
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High proliferative potential colony-forming cell heterogeneity identified using counterflow centrifugal elutriation.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow Cells | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Animals | |
| Cell Separation | |
| Centrifugation | |
| Colony-Forming Units Assay | |
| Granulocytes | |
| Hematopoietic Cell Growth Factors | |
| Macrophages | |
| Male | |
| Mice | |
| Mice, Inbred C3H | |
| Mice, Inbred C57BL | |
| Spleen |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1PO1 CA59348-01 | NCI NIH HHS | United States | PO1CA593480 | PubMed | NIH RePORTER |
| 1PO1 HL45168-02 | NHLBI NIH HHS | United States | PO1HL451680 | PubMed | NIH RePORTER |
| NHLBI HL08580-02 | NHLBI NIH HHS | United States | PubMed | PubMed | |
| P01CA059348 | NIH | NIH RePORTER | |||
| P01HL045168 | NIH | NIH RePORTER |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28593990 | Loss of Asxl2 leads to myeloid malignancies in mice. | Nat Commun | 2017 | https://conductscience.org/library/papers/28593990 | PubMed |
| 28228404 | Endothelial colony-forming cells ameliorate endothelial dysfunction via secreted factors following ischemia-reperfusion injury. | Am J Physiol Renal Physiol | 2017 | https://conductscience.org/library/papers/28228404 | PubMed |
| 24508729 | High proliferative potential endothelial colony-forming cells contribute to hypoxia-induced pulmonary artery vasa vasorum neovascularization. | Am J Physiol Lung Cell Mol Physiol | 2014 | https://conductscience.org/library/papers/24508729 | PubMed |
| 21486281 | Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells. | Br J Pharmacol | 2011 | https://conductscience.org/library/papers/21486281 | PubMed |
| 20348241 | Critical roles of lysosomal acid lipase in myelopoiesis. | Am J Pathol | 2010 | https://conductscience.org/library/papers/20348241 | PubMed |
| 19900502 | Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cells. | Exp Hematol | 2010 | https://conductscience.org/library/papers/19900502 | PubMed |
| 8552605 | Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8552605 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8329698
GET https://conductscience.org/api/papers/v1/8329698/authors